COMMUNIQUÉS West-GlobeNewswire

Stryker to announce financial results for its third quarter of fiscal year 2025
01/10/2025
Portage, Michigan, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its third quarter of fiscal year 2025 on Thursday, October 30, 2025. A press release will be [...]
ATMA CENA Grows National Mental Health Network to 13 Clinics
01/10/2025
Expanding access to safe, regulated psychedelic-assisted therapy across Canada CALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ATMA CENA, a Canadian mental health company specializing in psychedelic-assisted therapy [...]
Solid Biosciences to Present at Upcoming Scientific Meetings
01/10/2025
CHARLESTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from [...]
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
01/10/2025
- Meeting date aligns with prior guidance - - FDA to review AEON’s analytical development plan and initial data - IRVINE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: [...]
SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee
01/10/2025
TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. [...]
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
01/10/2025
FORT WORTH, TX, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025
CLEVELAND, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers
01/10/2025
BROOMFIELD, Colo., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented [...]
Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
01/10/2025
Awarded contract base period of US$3.6 million to fund vaccine manufacturing with additional option periods to advance development through Phase 1 trials Submitted up to US$97 million in additional U.S. government [...]
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
01/10/2025
– Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML – – FLT3 mutations occur in approximately 30% of newly diagnosed [...]
Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress
01/10/2025
LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced it will present new clinical data for avigbagene parvec (FLT201), its Phase 3-ready gene therapy candidate for Gaucher disease, at the European [...]
Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine
01/10/2025
Pilot study evaluates safety and tolerability of implantable neuromodulation therapy for erectile dysfunction following radical prostatectomy LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comphya SA, a [...]
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
01/10/2025
NEW HAVEN, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that two [...]
Athernal Bio Launches with £3.5 Million Funding from Delin Ventures
01/10/2025
Cambridge, UK, October 1, 2025 – Athernal Bio today announced its official launch alongside £3.5 million funding from founding investor Delin Ventures. The company is focused on the development of targeted [...]
Tessellate Bio Appoints Katie Chapman as Chief Scientific Officer
01/10/2025
NAARDEN, the Netherlands and STEVENAGE, United Kingdom, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, today announces the [...]
Inventiva Appoints Andrew Obenshain as Chief Executive Officer
01/10/2025
Daix (France), New York City (New York, United States), October 1, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development [...]
Inventiva annonce la nomination d’Andrew Obenshain au poste de Directeur Général
01/10/2025
Daix (France), New York City (New York, Etats-Unis), le 1 er octobre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
01/10/2025
If approved, leniolisib will be first and only treatment indicated for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on positive data [...]
Patient-Led NM Launches Statewide Summits and Video Campaign to Spotlight New Mexico’s Healthcare Crisis
01/10/2025
A Call for New Mexicans to Demand Policy Reform That Secures Timely Access to High-Quality Care Santa Fe, NM, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Patient-Led NM today announced the launch of a series of Healthcare [...]

Pages